Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Cardiff Oncology, Inc. (CRDF)

Compare
2.8700
-0.1400
(-4.65%)
At close: April 3 at 4:00:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
683
683
488
386
359
Gross Profit
244.6320
--
--
--
--
Operating Expense
49,334
49,334
45,900
40,288
29,214
Operating Income
-48,651
-48,651
-45,412
-39,902
-28,855
Net Non Operating Interest Income Expense
3,259
3,259
4,069
1,581
264
Other Income Expense
-39
-39
-98
-383
300
Pretax Income
-45,431
-45,431
-41,441
-38,704
-28,291
Net Income Common Stockholders
-45,455
-45,455
-41,465
-38,728
-28,315
Diluted NI Available to Com Stockholders
-45,455
-45,455
-41,465
-38,728
-28,315
Basic EPS
-0.95
--
-0.93
-0.89
-0.73
Diluted EPS
-0.95
--
-0.93
-0.89
-0.73
Basic Average Shares
47,650
--
44,677
43,600
39,030
Diluted Average Shares
47,650
--
44,677
43,600
39,030
Total Operating Income as Reported
-48,651
-48,651
-45,412
-39,902
-28,855
Total Expenses
49,334
49,334
45,900
40,288
29,214
Net Income from Continuing & Discontinued Operation
-45,431
-45,431
-41,441
-38,704
-28,291
Normalized Income
-45,431
-45,431
-41,441
-38,704
-28,576
Interest Income
3,259
3,259
4,069
1,581
264
Net Interest Income
3,259
3,259
4,069
1,581
264
EBIT
-48,651
-48,651
-45,412
-39,902
-28,855
EBITDA
-48,247
-48,247
-45,014
-39,666
-28,404
Reconciled Depreciation
404
404
398
236
451
Net Income from Continuing Operation Net Minority Interest
-45,431
-45,431
-41,441
-38,704
-28,291
Total Unusual Items Excluding Goodwill
--
--
--
--
285
Total Unusual Items
--
--
--
--
285
Normalized EBITDA
-48,247
-48,247
-45,014
-39,666
-28,689
12/31/2021 - 7/27/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IMUX Immunic, Inc.
1.0500
-5.41%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.5635
+0.32%
 
VSTM Verastem, Inc.
5.70
-2.40%
 
CADL Candel Therapeutics, Inc.
5.25
-1.13%
 
CRVS Corvus Pharmaceuticals, Inc.
2.9900
-6.85%
 
SLS SELLAS Life Sciences Group, Inc.
1.1000
+0.92%
 
MURA Mural Oncology plc
1.2300
-6.82%
 
TERN Terns Pharmaceuticals, Inc.
2.3300
-6.43%
 
PDSB PDS Biotechnology Corporation
1.0500
-9.09%
 
INMB INmune Bio, Inc.
7.77
-3.72%